Sun Pharmaceutical Industries

Price chart

Previous close

₹1,915.00

Open

₹1,915.20

Day high

₹1,943.90

Day low

₹1,900.60

Listed on NSE since 8 February 1995.

Futures and options

Futures, 23 Nov expiry

₹1,915.00

Premium to the share price

+5.60 (+0.29%)

Futures open interest

56,830 contracts (+878 today)

Lot size (NOV 26)

350 shares

Source: NSE, 09-Nov-2026 12:04:22, delayed. Option chain · All futures · Lot sizes

Pivot levels

R3

1,935.23

R2

1,902.07

R1

1,881.03

CPR top

1,853.93

Pivot

1,847.87

CPR bottom

1,841.80

S1

1,826.83

S2

1,793.67

S3

1,772.63

From Friday 6 November’s high, low and close (Yahoo Finance). Arithmetic on past prices, not a forecast.

Market value

₹4,59,473 Cr

P/E (trailing)

41.90

EPS (trailing)

₹45.70

Price to book

5.14

Dividend yield

0.86%

Return on equity

13.1%

Debt to equity

0.04

Profit margin

17.8%

Beta

0.13

Volume today

16.52 L

Average volume

17.46 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Sun Pharmaceutical Industries’s results filed with NSE, consolidated (the whole group). Net profit is the share of Sun Pharmaceutical Industries’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Sun Pharmaceutical Industries’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

47,000

Company website · Profile: Yahoo Finance

No headlines name Sun Pharmaceutical Industries in the last day or two.

• Dividend - Rs 5 Per Share

  Dividend · ex-date 7 July 2026

• Interim Dividend - Rs 11 Per Share

  Dividend · ex-date 5 February 2026

• Dividend - Rs 5.50 Per Share

  Dividend · ex-date 7 July 2025

• Interim Dividend - Rs 10.50 Per Share

  Dividend · ex-date 6 February 2025

• Dividend - Rs 5 Per Share

  Dividend · ex-date 12 July 2024

• Interim Dividend - Rs 8.50 Per Share

  Dividend · ex-date 9 February 2024

• Dividend - Rs 4 Per Share

  Dividend · ex-date 28 July 2023

• Interim Dividend - Rs 7.50 Per Share

  Dividend · ex-date 8 February 2023

Source: NSE. Latest first, 8 of 20.